Zacks Research Analysts Lower Earnings Estimates for Amdocs

Amdocs Limited (NASDAQ:DOX) – Zacks Research cut their Q1 2025 earnings per share estimates for Amdocs in a report issued on Tuesday, December 3rd. Zacks Research analyst R. Department now expects that the technology company will post earnings of $1.48 per share for the quarter, down from their prior forecast of $1.52. The consensus estimate for Amdocs’ current full-year earnings is $6.18 per share. Zacks Research also issued estimates for Amdocs’ Q4 2025 earnings at $1.65 EPS, FY2025 earnings at $6.21 EPS, Q2 2026 earnings at $1.66 EPS, Q4 2026 earnings at $1.75 EPS and FY2026 earnings at $6.72 EPS.

DOX has been the topic of a number of other reports. Oppenheimer lifted their price objective on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Stifel Nicolaus assumed coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 target price for the company. StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 14th. Finally, Barclays decreased their price objective on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $101.20.

Amdocs Trading Down 0.5 %

NASDAQ DOX opened at $86.64 on Friday. Amdocs has a 52 week low of $74.41 and a 52 week high of $94.04. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.20. The stock’s 50 day moving average price is $88.12 and its two-hundred day moving average price is $84.25. The stock has a market capitalization of $10.18 billion, a price-to-earnings ratio of 20.43, a PEG ratio of 1.46 and a beta of 0.72.

Hedge Funds Weigh In On Amdocs

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Pzena Investment Management LLC lifted its holdings in Amdocs by 33.2% during the 2nd quarter. Pzena Investment Management LLC now owns 5,667,603 shares of the technology company’s stock worth $447,287,000 after purchasing an additional 1,412,826 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Amdocs by 36.6% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company’s stock valued at $277,818,000 after acquiring an additional 851,022 shares during the period. Brandes Investment Partners LP boosted its position in shares of Amdocs by 31.1% in the second quarter. Brandes Investment Partners LP now owns 2,260,811 shares of the technology company’s stock valued at $178,335,000 after acquiring an additional 536,359 shares during the period. Pacer Advisors Inc. increased its position in Amdocs by 36.2% during the second quarter. Pacer Advisors Inc. now owns 1,675,784 shares of the technology company’s stock worth $132,253,000 after acquiring an additional 444,966 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC raised its stake in Amdocs by 123.2% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 759,136 shares of the technology company’s stock worth $66,409,000 after purchasing an additional 419,045 shares in the last quarter. 92.02% of the stock is owned by institutional investors.

Amdocs Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs’s payout ratio is currently 45.28%.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.